Table of Content


1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Autoimmune Disease Diagnostics Market


6. Market Share – Autoimmune Disease Diagnostics Market

6.1 By Type
6.2 By Disease
6.3 By End Users
6.4 By Region


7. Type – Autoimmune Disease Diagnostics Market

7.1 Systemic Autoimmune Disease Diagnostics
7.2 Localized Autoimmune Disease Diagnostics


8. Disease – Autoimmune Disease Diagnostics Market

8.1 Systemic Lupus Erythematosus
8.2 Thyroiditis
8.3 Rheumatoid Arthritis
8.4 Sj?gren’s Syndrome
8.5 Scleroderma
8.6 Others


9. End Users – Autoimmune Disease Diagnostics Market

9.1 Hospitals
9.2 Clinical Laboratories
9.3 Others


10. Region – Autoimmune Disease Diagnostics Market

10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Middle East & Africa
10.5 Latin America


11. Porters Five Forces

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes


12. Company Analysis

12.1 Abbott Laboratories

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Financial Insights

12.2 Bio-Rad Laboratories

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Financial Insights

12.3 Roche Diagnostics

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Financial Insights

12.4 Siemens Healthineers

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Financial Insights

12.5 bioMerieux SA

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Financial Insights



List of Figures


Figure-01: Global Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-02: Forecast for – Global Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-03: Type – Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-04: Type – Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-05: Type – Localized Autoimmune Disease Diagnostics Market (Billion US$), 2016 – 2021
Figure-06: Type – Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2022 – 2027
Figure-07: Disease – Systemic Lupus Erythematosus Market (Million US$), 2016 – 2021
Figure-08: Disease – Forecast for Systemic Lupus Erythematosus Market (Million US$), 2022 – 2027
Figure-09: Disease – Thyroiditis Market (Million US$), 2016 – 2021
Figure-10: Disease – Forecast for Thyroiditis Market (Million US$), 2022 – 2027
Figure-11: Disease – Rheumatoid Arthritis Market (Million US$), 2016 – 2021
Figure-12: Disease – Forecast for Rheumatoid Arthritis Market (Million US$), 2022 – 2027
Figure-13: Disease – Sj?gren’s Syndrome Market (Million US$), 2016 – 2021
Figure-14: Disease – Forecast for Sj?gren’s Syndrome Market (Million US$), 2022 – 2027
Figure-15: Disease – Scleroderma Market (Million US$), 2016 – 2021
Figure-16: Disease – Forecast for Scleroderma Market (Million US$), 2022 – 2027
Figure-17: Disease – Others Market (Million US$), 2016 – 2021
Figure-18: Disease – Forecast for Others Market (Million US$), 2022 – 2027
Figure-19: End Users – Hospitals Market (Billion US$), 2016 – 2021
Figure-20: End Users – Forecast for Hospitals Market (Billion US$), 2022 – 2027
Figure-21: End Users – Clinical Laboratories Market (Billion US$), 2016 – 2021
Figure-22: End Users – Forecast for Clinical Laboratories Market (Billion US$), 2022 – 2027
Figure-23: End Users – Others Market (Million US$), 2016 – 2021
Figure-24: End Users – Forecast for Others Market (Million US$), 2022 – 2027
Figure-25: North America – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-26: North America – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-27: Europe – Autoimmune Disease Diagnostic Market (Billion US$), 2016 – 2021
Figure-28: Europe – Forecast for Autoimmune Disease Diagnostic Market (Billion US$), 2022 – 2027
Figure-29: Asia Pacific – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-30: Asia Pacific – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-31: Middle East & Africa – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-32: Middle East & Africa – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-33: Latin America – Autoimmune Disease Diagnostic Market (Million US$), 2016 – 2021
Figure-34: Latin America – Forecast for Autoimmune Disease Diagnostic Market (Million US$), 2022 – 2027
Figure-35: Abbott Laboratories – Global Revenue (Billion US$), 2016 – 2021
Figure-36: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-37: Bio-Rad Laboratories – Global Revenue (Billion US$), 2016 – 2021
Figure-38: Bio-Rad Laboratories – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-39: Roche Diagnostics – Global Revenue (Billion US$), 2016 – 2021
Figure-40: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-41: Siemens Healthineers – Global Revenue (Billion US$), 2016 – 2021
Figure-42: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-43: bioMerieux SA – Global Revenue (Billion US$), 2016 – 2021
Figure-44: bioMerieux SA – Forecast for Global Revenue (Billion US$), 2022 – 2027

List of Tables


Table-01: Global – Autoimmune Disease Diagnostic Market Share by Type (Percent), 2016 – 2021
Table-02: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Type (Percent), 2022 – 2027
Table-03: Global – Autoimmune Disease Diagnostic Market Share by Disease (Percent), 2016 – 2021
Table-04: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Disease (Percent), 2022 – 2027
Table-05: Global – Autoimmune Disease Diagnostic Market Share by End User (Percent), 2016 – 2021
Table-06: Global – Forecast for Autoimmune Disease Diagnostic Market Share by End User (Percent), 2022 – 2027
Table-07: Global – Autoimmune Disease Diagnostic Market Share by Region (Percent), 2016 – 2021
Table-08: Global – Forecast for Autoimmune Disease Diagnostic Market Share by Region (Percent), 2022 – 2027